Construction method of model for predicting curative effect of PD-1

The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHENG LIMOU, HU JING, YANG SHUANG, ZHENG FANGKE
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHENG LIMOU
HU JING
YANG SHUANG
ZHENG FANGKE
description The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is not subjected to other treatments during the period; 2) after the patient is subjected to PD-1/PD-L1treatment, performing CT scanning every three months; 3) performing conventional RNA-seq sequencing on the sample; (4) analyzing RNA-seq biological information; 5) constructing and screening RNA-seq data characteristics for predicting the curative effect of the PD-1; and 6) constructing the model for predicting the curative effect of the PD-1. Compared with a conventional PD-1 curative effect prediction molecular marker , an RNA sequencing molecular marker is more accurate in prediction result, and lower in cost. 本发明公开了一种用于预测PD-1疗效的模型的构建方法,包括如下步骤:1)选取用药时间前一个月内穿刺或石蜡组织的样本的RNA-seq作为基线,患者在此期间内未接受其他治疗;2)患者进行PD-1/PD-L1治疗后,每
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN111883203A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN111883203A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN111883203A3</originalsourceid><addsrcrecordid>eNrjZHB2zs8rLikqTS7JzM9TyE0tychPUchPU8jNT0nNUUjLL1IoKEpNyQRK56UrJJcWJZZklqUqpKalpSaXgNQFuOga8jCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_Q0NDCwtjIwNjR2Ni1AAATIExuQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Construction method of model for predicting curative effect of PD-1</title><source>esp@cenet</source><creator>ZHENG LIMOU ; HU JING ; YANG SHUANG ; ZHENG FANGKE</creator><creatorcontrib>ZHENG LIMOU ; HU JING ; YANG SHUANG ; ZHENG FANGKE</creatorcontrib><description>The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is not subjected to other treatments during the period; 2) after the patient is subjected to PD-1/PD-L1treatment, performing CT scanning every three months; 3) performing conventional RNA-seq sequencing on the sample; (4) analyzing RNA-seq biological information; 5) constructing and screening RNA-seq data characteristics for predicting the curative effect of the PD-1; and 6) constructing the model for predicting the curative effect of the PD-1. Compared with a conventional PD-1 curative effect prediction molecular marker , an RNA sequencing molecular marker is more accurate in prediction result, and lower in cost. 本发明公开了一种用于预测PD-1疗效的模型的构建方法,包括如下步骤:1)选取用药时间前一个月内穿刺或石蜡组织的样本的RNA-seq作为基线,患者在此期间内未接受其他治疗;2)患者进行PD-1/PD-L1治疗后,每</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PHYSICS ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201103&amp;DB=EPODOC&amp;CC=CN&amp;NR=111883203A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201103&amp;DB=EPODOC&amp;CC=CN&amp;NR=111883203A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHENG LIMOU</creatorcontrib><creatorcontrib>HU JING</creatorcontrib><creatorcontrib>YANG SHUANG</creatorcontrib><creatorcontrib>ZHENG FANGKE</creatorcontrib><title>Construction method of model for predicting curative effect of PD-1</title><description>The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is not subjected to other treatments during the period; 2) after the patient is subjected to PD-1/PD-L1treatment, performing CT scanning every three months; 3) performing conventional RNA-seq sequencing on the sample; (4) analyzing RNA-seq biological information; 5) constructing and screening RNA-seq data characteristics for predicting the curative effect of the PD-1; and 6) constructing the model for predicting the curative effect of the PD-1. Compared with a conventional PD-1 curative effect prediction molecular marker , an RNA sequencing molecular marker is more accurate in prediction result, and lower in cost. 本发明公开了一种用于预测PD-1疗效的模型的构建方法,包括如下步骤:1)选取用药时间前一个月内穿刺或石蜡组织的样本的RNA-seq作为基线,患者在此期间内未接受其他治疗;2)患者进行PD-1/PD-L1治疗后,每</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PHYSICS</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB2zs8rLikqTS7JzM9TyE0tychPUchPU8jNT0nNUUjLL1IoKEpNyQRK56UrJJcWJZZklqUqpKalpSaXgNQFuOga8jCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_Q0NDCwtjIwNjR2Ni1AAATIExuQ</recordid><startdate>20201103</startdate><enddate>20201103</enddate><creator>ZHENG LIMOU</creator><creator>HU JING</creator><creator>YANG SHUANG</creator><creator>ZHENG FANGKE</creator><scope>EVB</scope></search><sort><creationdate>20201103</creationdate><title>Construction method of model for predicting curative effect of PD-1</title><author>ZHENG LIMOU ; HU JING ; YANG SHUANG ; ZHENG FANGKE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN111883203A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PHYSICS</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHENG LIMOU</creatorcontrib><creatorcontrib>HU JING</creatorcontrib><creatorcontrib>YANG SHUANG</creatorcontrib><creatorcontrib>ZHENG FANGKE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHENG LIMOU</au><au>HU JING</au><au>YANG SHUANG</au><au>ZHENG FANGKE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Construction method of model for predicting curative effect of PD-1</title><date>2020-11-03</date><risdate>2020</risdate><abstract>The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is not subjected to other treatments during the period; 2) after the patient is subjected to PD-1/PD-L1treatment, performing CT scanning every three months; 3) performing conventional RNA-seq sequencing on the sample; (4) analyzing RNA-seq biological information; 5) constructing and screening RNA-seq data characteristics for predicting the curative effect of the PD-1; and 6) constructing the model for predicting the curative effect of the PD-1. Compared with a conventional PD-1 curative effect prediction molecular marker , an RNA sequencing molecular marker is more accurate in prediction result, and lower in cost. 本发明公开了一种用于预测PD-1疗效的模型的构建方法,包括如下步骤:1)选取用药时间前一个月内穿刺或石蜡组织的样本的RNA-seq作为基线,患者在此期间内未接受其他治疗;2)患者进行PD-1/PD-L1治疗后,每</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN111883203A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
title Construction method of model for predicting curative effect of PD-1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A36%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHENG%20LIMOU&rft.date=2020-11-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN111883203A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true